Timentin and Amphotericin b drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Timentin (clavulanate potassium; ticarcillin disodium) and Amphotericin b (amphotericin b). Common drug interactions include pleural effusion among females and acute lymphocytic leukaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Timentin and Amphotericin b. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Timentin?

Timentin has active ingredients of clavulanate potassium; ticarcillin disodium. eHealthMe is studying from 624 Timentin users. Check the latest studies of Timentin.

What is Amphotericin b?

Amphotericin b has active ingredients of amphotericin b. It is often used in thrush. eHealthMe is studying from 16,275 Amphotericin b users. Check the latest studies of Amphotericin b.



On Jul, 10, 2026

15 people who take Timentin and Amphotericin b together, and have interactions are studied.

Timentin and Amphotericin b drug interactions.

What are the common drug interactions of Timentin and Amphotericin B, by gender? *:

female:

  1. Pleural effusion (water on the lungs)
  2. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  3. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
  4. Cardiac arrest
  5. Colitis (inflammation of colon)
  6. Hypotension (abnormally low blood pressure)
  7. Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
  8. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Adult respiratory distress syndrome (type of lung (pulmonary) failure)

male:

  1. Acute lymphocytic leukaemia (cancer of the white blood cells)
  2. Endocarditis staphylococcal (an inflammation of the inner layer of the heart by staphylococcal bacterial infection)
  3. Back pain
  4. Blood creatine increased
  5. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  6. Constipation
  7. Cytomegalovirus infection
  8. Eating disorder
  9. Febrile neutropenia (fever with reduced white blood cells)
  10. Headache (pain in head)

What are the common drug interactions of Timentin and Amphotericin B, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Acute lymphocytic leukaemia (cancer of the white blood cells)
  2. Endocarditis staphylococcal (an inflammation of the inner layer of the heart by staphylococcal bacterial infection)
  3. Septicaemia staphylococcal (blood infection with bacteria)
  4. Arthralgia (joint pain)
  5. Back pain
  6. Drug clearance decreased
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Osteonecrosis (death of bone)
  10. Renal failure acute (rapid kidney dysfunction)

20-29:

  1. Blood creatine increased
  2. Headache (pain in head)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Nuclear magnetic resonance imaging brain
  5. Osteomyelitis (infection of bone)
  6. Pneumonia
  7. Pulmonary artery thrombosis (blockage of the main artery of the lung)
  8. Pyrexia (fever)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Sinusitis (inflammation of sinus)

30-39:

  1. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
  2. Cardiac arrest
  3. Colitis (inflammation of colon)
  4. Hypotension (abnormally low blood pressure)
  5. Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. International normalised ratio increased
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Sudden death unexplained

40-49:

  1. B-cell lymphoma (blood cancer affecting b cells)
  2. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  3. Constipation
  4. Cytomegalovirus infection
  5. Eating disorder
  6. Impaired healing
  7. Lethargy (tiredness)
  8. Lymphocele (a collection of lymphatic fluid within the body not bordered by epithelial lining)
  9. Lymphoproliferative disorder (a medical condition in which the immune system makes too many white blood cells)
  10. Multi-organ failure (multisystem organ failure)

50-59:

  1. Adult respiratory distress syndrome (type of lung (pulmonary) failure)
  2. Lung disorder (lung disease)
  3. Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
  4. Multi-organ failure (multisystem organ failure)
  5. Renal failure (kidney dysfunction)
  6. Renal impairment (severely reduced kidney function)

60+:

n/a

What are the existing conditions these people have? *

  1. High Blood Pressure: 4 people, 26.67%
  2. Diarrhea: 3 people, 20.00%
  3. Agitation (state of anxiety or nervous excitement): 3 people, 20.00%
  4. Pneumonia: 3 people, 20.00%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 20.00%
  6. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 20.00%
  7. Leukocytosis (increased white blood cells): 3 people, 20.00%
  8. Hypokalemia (low potassium): 3 people, 20.00%
  9. Hyperglycemia (high blood sugar): 3 people, 20.00%
  10. Constipation: 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Timentin and Amphotericin b?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Timentin and Amphotericin b:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Timentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amphotericin b:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Timentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amphotericin b and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clavulanate potassium; ticarcillin disodium and amphotericin b (the active ingredients of Timentin and Amphotericin b, respectively), and Timentin and Amphotericin b (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: